Why the Modi Government’s ‘Positivity’ Narrative on COVID-19 Vaccination Plan Doesn’t Add Up

If the Authorities of India is to be believed, Indians have a lot to rejoice – and be optimistic about – today. That sounds good, till you scratch on the floor of the its claims.

“Have fun the facility of positivity and the strengths of 130 crore Indians” – Prime Minister Narendra Modi exhorted in a tweet. There needs to be “higher communication” of the federal government’s “optimistic” work – so went the message to officers of the Authorities of India (GoI) throughout an official workshop. Counter the “one-sided narrative” in opposition to India within the world media, Indian embassies and excessive commissions had been instructed by the minister for exterior affairs.

As lifeless our bodies float round within the holy Ganges, as folks die for lack of oxygen or ICU beds, as crematoriums run out of area for funerals, and because the “pharmacy of the world” runs aground for lack of vaccines, the Authorities of India (GoI) is actually ducking for canopy. The oft-employed anti-national tag to silence these elevating questions is long gone its expiry worth. So, a contemporary spin is so as. “Be optimistic.” Don’t unfold “negativity”.

However positivity can’t be manufactured from nowhere. To be efficient, it must be based mostly on details, and on fact. Given the extraordinary failure of planning and a complete lack of engagement with the disaster, all effort to unfold positivity has ended up being based mostly on half-truths and exaggerations. That is exactly what India has witnessed over the numerous night press conferences of the GoI on the pandemic.

I watched the federal government’s press convention of Could 13, 2021. An excellent portion of it was supposed to instil positivity about India’s vaccine coverage and plans. However an in depth perusal of the statements and the slides introduced there truly confirms simply how dire the state of affairs is.

1. Meaningless declare on share of world vaccinations

The press convention started with Determine 1 beneath. V.Ok. Paul, member of the NITI Aayog, introduced Determine 1 and claimed that of all of the vaccine doses given on this planet, 13% got in India. What does this determine of 13% imply? Nothing. However his voice modulation modified with an emphasis when he stated 13%, as if it was one thing vital. You consider it once more. You verify the share of India’s inhabitants on this planet inhabitants. It’s about 18%. The share of vaccines administered is at the least 5 proportion factors decrease than the share in world inhabitants. Seen from this angle, the file is poor. Why the emphasis then?

You assume tougher. The prime minister had claimed that “India [is] operating world’s largest COVID-19 vaccination drive”. You have a look at Determine 1 once more. Even in absolute phrases, this declare is unfaithful as on Could 13, 2021. China and the USA had given extra doses of vaccines than India, although the inhabitants of the US is smaller than India’s. That’s when Paul clears the air on the explanation for the emphasis. He says: “Desh ke liye, ye jo narrative hai, optimistic narrative jo hai, desh ke liye garv karne wala jo narrative hai, yeh bhi ek sachai hai [For the country, this narrative, the positive narrative, the narrative that makes you proud of the country, that is also a truth].” You see, it was not about details; it was about positivity.

Determine 1 from the GoI presentation, dated Could 13, 2021.

What’s the actuality? Normalised to inhabitants dimension, i.e., variety of doses administered per 100 individuals, India’s efficiency in vaccination protection was extraordinarily poor as on Could 13, 2021 (see Determine 2). The variety of doses administered per 100 individuals was greater than 100 in Israel and UAE, 85 in Chile, 81 in the UK, 79 in the USA, 46 in Germany and 25 in China. For India, the corresponding determine was simply 13. There isn’t any garv on this graph. For that purpose, we are going to by no means be proven such a graph.

Determine 2, dated Could 13, 2021.

2. Meaningless comparability on ‘variety of days’ taken to achieve 170 million vaccinations

The following graph within the presentation was equally amusing (see Determine 3). This can be a graph that finds a spot in each press convention: variety of days taken to achieve “x” variety of vaccinations. We’re informed that India reached the 17 crore mark in 114 days, whereas the USA took 115 days. That is introduced as a matter of success, which helps unfold the spirit of positivity even in dire instances.

Determine 3.

Nevertheless, a better look reveals this too is meaningless. The share of people that obtained at the least one dose of the vaccine within the US was about 46% on Could 12, whereas it was solely about 10% in India. As nations just like the US close to the 50% mark, progress will certainly decelerate for a number of causes; difficulties in reaching distant and rural areas, vaccine hesitancy and encounters with anti-vaxxers are among the many causes. Shifting from 50% to 60% within the US can be slower than shifting from 10% to 20% in India; in reality, it needs to be a cakewalk in India given the thousands and thousands ready to get an appointment within the CoWIN app. But, India strikes as sluggish as a tortoise. Thus, whereas Determine Three is put out as a measure of success, it truly reveals an issue.

3. Deceptive declare on precise vaccine availability in India

Then got here one other slide on vaccine availability in India (see Determine 4). There was no new data on this desk aside from what earlier shows had already informed us. However right here once more, it was a matter of emphasis. The determine of 35.6 crore was emphasised although this was a cumulative determine from January 2021 operating as much as July 2021. As well as, 16 crore doses are ordered by states and personal hospitals for supply between Could and July 2021. So, the whole is 51.6 crore doses. Left to itself, this slide leaves a layman with the impression that the GoI has executed a commendable job. Is it true?

Determine 4.

The issue with Determine Four is that there isn’t any messaging on whether or not that is an sufficient amount or not. I had addressed this matter in an article written for Scroll.in on Could 11, 2021; I shall refer readers to Desk 1 in my article. What’s necessary is to see the doses obtainable with the GoI, state governments and personal hospitals over three months viz., Could, June and July 2021. Desk 1, reproduced beneath as Determine 5, reveals the next.

Determine 5.

The desk in Determine 5 tells us that the GoI would have a mean entitlement of 21.Four lakh vaccine doses per day in Could, June and July. Nevertheless, the typical manufacturing capability of vaccines in India in Could 2021 is simply about 23 lakh doses per day, as a later slide in the identical press convention confirmed. Thus, of the 23 lakh doses per day, the GoI would purchase 21.Four lakh doses per day. After setting apart part of the manufacturing capability for personal hospitals, the share of doses left for the State governments between Could and July 2021 can be miniscule. Even when we liberally repair India’s manufacturing capability at 28 lakh doses per day, the state of affairs stays largely the identical.

In different phrases, the “16 crore further doses” cited for states and personal hospitals is an irrelevant quantity. 16 crore doses for Three months imply 17 lakh doses per day. To satisfy this demand from states, India ought to produce at the least 38 lakh doses per day. Nevertheless, we don’t produce that. States could finally obtain 16 crore doses, however just some months after July 2021. Thus, there’s a world of distinction between the impression created via Determine Four and the fact depicted in Determine 5.

4. Projecting ‘2 bn doses’ based mostly on untested vaccines, unexplained manufacturing will increase

The star of all slides was solely to comply with (see Determine 6). This desk confirmed the “rising vaccine availability” in India between August and December 2021. It confirmed that India would actually be flooded with vaccines on this interval totalling 216 crore doses over 5 months. This means a leap, quite a significant leap, of manufacturing capability/availability from about 23 lakh doses per day to about 1.Four crore doses per day – a six-fold rise!

To start with, most vaccines referred to in Determine 6 are solely within the trial stage and we don’t even know if they’d go all of the levels of checks. Assuming they do go, it’s not in any respect clear if manufacturing capability exists to fulfil these targets.

Determine 6.

The declare is that the Serum Institute of India (SII) will produce 95 crore doses in 5 months (75 crore doses of Covishield and 20 crore doses of Novavax/Covavax). In different phrases, SII’s capability would rise about three-fold from the current 21-22 lakh doses per day to about 64 lakh doses per day. Allow us to keep in mind that SII has already been struggling to satisfy an earlier promise of manufacturing 33 lakh doses per day by July 2021; that is partly resulting from an unintentional fireplace incident in SII in early 2021 and partly resulting from export restrictions within the US with respect to particular pumps and filtration items wanted to make vaccines. It’s, thus, extremely unlikely that SII would produce 64 lakh doses per day earlier than December 2021.

The opposite declare in Determine 6 is on Covaxin. If 55 crore doses of Covaxin are to be produced over 5 months, the manufacturing capability ought to rise from the current 5 lakh to seven lakh doses per day to 37 lakh doses per day. Bharat Biotech is on file stating that their capability could rise to 19 lakh doses per day, however solely by December 2021 or January 2022. The GoI’s affidavit to the Supreme Court docket states that the manufacturing capability of Covaxin will rise from three lakh doses per day to 33 lakh doses per day “over the subsequent 8-10 months”. So, by all prospects, we will produce Covaxin at round 33 lakh doses per day (or 37 lakh doses per day, as within the slides of the GoI) in December 2021 or January 2022. Not earlier than that.

The remainder of the Covaxin doses promised in Determine 6 should come from the three public sector items which are supplied with new licenses. Nevertheless, of those three items, Haffkine Institute will be capable to produce the primary batch of vaccines not earlier than six months after April 2021, if not 12 months. The identical holds true for the opposite two items additionally. The GoI has put aside Rs 200 crore as a grant-in-aid to those three items. On the identical time, the GoI’s affidavit says that “grant-in-aid has been advisable; nevertheless, disbursements have but to be made”. In different phrases, no funds have been made as but – a positive indication of forthcoming delays.

So, the place are the remainder of the Covaxin doses going to come back from? There may be zero readability.

It’s fairly potential that some further doses of Covishield, Covaxin and different vaccines like Sputnik V would begin trickling in between August and December 2021. Nevertheless, the numbers cited in Determine 6 are unrealistic and unsuitable. It will be important that in its efforts to unfold positivity, the GoI shouldn’t disseminate falsehoods. Positivity can be finest served by the dissemination of fact, how a lot ever unpalatable.

5. Actuality is day by day vaccine doses are falling, not rising

The important thing story that emerges from the vaccine coverage of India in April and Could is a large scarcity of vaccines, due to which the variety of doses administered fell from round 42 lakh doses per day in early April to 27 lakh doses per day by end-April and 23 lakh doses as on 13 Could (see Determine 7, for a plot of seven-day shifting common of day by day doses). In impact, our day by day vaccination price has intently adopted our day by day manufacturing capability after mid-April.

Determine 7.

The GoI ought to, first, present Indian folks with a transparent clarification for why this fall in day by day vaccination price occurred. That is likely to be a great place to begin for an trustworthy dialog between the federal government and folks, based mostly on details and fact. Bombastic claims and projections needs to be averted.

R. Ramakumar is Professor, Tata Institute of Social Sciences, Mumbai.

Scroll to Top